RSE eLearning - Page 3
Pregnancy and Lactation Labeling Rule (PLLR): How to Read FDA Drug Safety Info
The FDA's Pregnancy and Lactation Labeling Rule (PLLR) replaced outdated letter categories with clear, evidence-based safety info for pregnant and breastfeeding women. Learn how to read the new labels and make informed medication decisions.
Read More
What Are Drug Side Effects: Definition, Causes, and Real-World Examples
Learn what drug side effects really are, why they happen, and how common they are - with real examples, causes, and practical tips for managing them safely. Understand the difference between minor and serious reactions.
Read More
The 80-125% Rule: Understanding Bioequivalence Confidence Intervals for Generic Drugs
The 80-125% rule ensures generic drugs are absorbed the same way as brand-name versions. Learn how bioequivalence confidence intervals work, why they matter, and what the data really says about generic safety.
Read More
Biologic Patent Protection: When Biosimilars Can Enter the U.S. Market
Biologic drugs in the U.S. enjoy 12 years of market exclusivity before biosimilars can enter, thanks to FDA rules and patent thickets. This delays competition, keeps prices high, and leaves patients paying more than those in other countries.
Read More
Bursitis and Tendinitis: How to Tell Them Apart and Treat Them Right
Bursitis and tendinitis cause joint pain but affect different tissues. Learn how to tell them apart, what treatments actually work, and why misdiagnosis delays recovery by weeks.
Read More
Autoimmune Overlap: Understanding PBC, PSC, and AIH Combined Features
Autoimmune overlap syndromes combine features of PBC, PSC, and AIH, requiring specialized diagnosis and dual treatment. Learn how to spot the signs and why standard therapies often fail.
Read More
Creatine and Kidney Disease Medications: How to Monitor Renal Function Safely
Creatine can falsely raise creatinine levels, leading to misdiagnosis of kidney disease. Learn how to monitor kidney function safely if you're on kidney meds or have CKD - without stopping your supplement.
Read More
Patient Communication in Drug Shortages: What Providers Must Do
When drugs run short, providers must communicate clearly, honestly, and empathetically. Learn what patients need to hear, how to explain alternatives, and why failing to act can break trust-and risk safety.
Read More
Chinese Generic Production: Manufacturing and Quality Concerns in Global Pharma
Chinese manufacturers produce 80% of the world's generic drug ingredients, offering low prices but raising serious quality concerns. Learn how supply chain risks, regulatory gaps, and inconsistent safety standards affect the medicines you take.
Read More
Provider Education: Understanding Biosimilar Differences
Biosimilars are not generics. They're complex biological drugs that require special understanding. Learn how they differ, why provider education matters, and how to confidently use them in practice.
Read More
Hemochromatosis: How Iron Overload Damages Your Liver and How Phlebotomy Fixes It
Hemochromatosis is a common genetic disorder that causes dangerous iron buildup, especially in the liver. Phlebotomy - regular blood removal - is the proven, low-cost treatment that can prevent cirrhosis, diabetes, and liver cancer if started early.
Read More
Regulatory Exclusivity: How Non-Patent Protections Delay Generic Drugs
Regulatory exclusivity is a government-granted market protection that delays generic drug approval, independent of patents. It gives drugmakers 5 to 12 years of exclusive sales rights and plays a major role in high drug prices.
Read More